HC Wainwright & Co. Downgrades Ventyx Biosciences to Neutral
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Emily Bodnar has downgraded Ventyx Biosciences (NASDAQ:VTYX) from Buy to Neutral.

November 07, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ventyx Biosciences has been downgraded from Buy to Neutral by HC Wainwright & Co.
The downgrade from Buy to Neutral by a reputable analyst at HC Wainwright & Co. could potentially lead to a decrease in the stock price of Ventyx Biosciences in the short term as it may influence investor sentiment and decision making.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100